ISSN 1662-4009 (online)

Previous issue | Volume 16 | ESPEYB16 | Next issue

Yearbook of Paediatric Endocrinology 2019

4. Growth and Growth Factors

Important for Clinical Practice

ey0016.4-1 | Important for Clinical Practice | ESPEYB16

4.1. Growth hormone improves short-term growth in patients with temple syndrome

DS Brightman , O Lokulo-Sodipe , B Searle , DJG Mackay , JH Davies , IK Temple , A Dauber

To read the full abstract: Horm Res Paediatr. 2018;90:407–413.Temple syndrome (TS) is a rare imprinting disorder caused by the dysregulation of imprinted genes in the chromosomal region 14q32 [1]. Most cases (approximately 70–80%) are caused by maternal uniparental disomy of chromosome 14. Paternal deletions and primary imprinting defects involving chromosomal region 14q32 can ...

ey0016.4-2 | Important for Clinical Practice | ESPEYB16

4.2. Improved mental and motor development during 3 years of GH treatment in very young children with Prader-Willi syndrome

SH Donze , L Damen , EF Mahabier , ACS Hokken-Koelega

To read the full abstract: J Clin Endocrinol Metab 2018 pii: jc.2018-00687.Prader-Willi syndrome (PWS) is a rare genetic disorder secondary to absent expression of the paternal active genes in the PWS critical region of chromosome 15. 70% of patients have a microdeletion, 28% a uniparental disomy (UPD) and 1% an imprinting defect. PWS has an estimated incidence rate of 1 in 25,000 live b...

ey0016.4-3 | Important for Clinical Practice | ESPEYB16

4.3. High prevalence of growth plate gene variants in children with familial short stature treated with growth hormone

L Plachy , V Strakova , L Elblova , B Obermannova , S Kolouskova , M Snajderova , D Zemkova , P Dusatkova , Z Sumnik , J Lebl , S Pruhova

J Clin Endocrinol Metab. 2019 Feb. doi: 10.1210/jc.2018-02288. [Epub ahead of print]Short stature is the most common reason for referral to pediatric endocrinologists. Familial short stature (FSS) is used to describe a child with a stature below the normal but within the parental target range and with at least one short parent.In the last years, there has been a widesp...

ey0016.4-4 | Important for Clinical Practice | ESPEYB16

4.4. Phenotypic features and response to growth hormone treatment of patients with a molecular defect of the IGF-1 receptor

MJE Walenkamp , JML Robers , JM Wit , GRJ Zandwijken , HA van Duyvenvoorde , W Oostdijk , ACS Hokken-Koelega , SG Kant , M Losekoot

To read the full abstract: J Clin Endocrinol Metab. 2019; 104(8): 3157–3171.The IGF receptor gene IGF1R is located at 15q26.3 locus and encodes for a tyrosine kinase receptor which mediates the IGF-I biological actions. The key role of IGF-IR in growth and development was proved in IGF1R null mice that had severely impaired prenatal growth and invariably died at birth ...